CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 5, 2024 · earnings

VRCA earnings: a negative outcome, -44.2%

On November 5, 2024, Verrica Pharmaceuticals Inc. reached its earnings. The result was a negative outcome, and the stock moved -44.2% in the window around the event. It had already run +16.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$14.30
1d before
$7.98
Event day
$7.46
1d after
$8.30
5d after

Pre-catalyst setup

+16.8%
30-day run-up
9104%
30-day volatility
0.5×
volume spike